UnitedHealth Group Incorporated $UNH Position Increased by Tredje AP fonden

Tredje AP fonden increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 459,417 shares of the healthcare conglomerate’s stock after acquiring an additional 110,583 shares during the quarter. UnitedHealth Group accounts for about 1.3% of Tredje AP fonden’s holdings, making the stock its 14th largest position. Tredje AP fonden owned approximately 0.05% of UnitedHealth Group worth $158,637,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Stevens Capital Management LP grew its holdings in shares of UnitedHealth Group by 21.6% during the third quarter. Stevens Capital Management LP now owns 7,158 shares of the healthcare conglomerate’s stock valued at $2,472,000 after buying an additional 1,272 shares in the last quarter. Smead Capital Management Inc. grew its stake in UnitedHealth Group by 30.8% during the 3rd quarter. Smead Capital Management Inc. now owns 330,118 shares of the healthcare conglomerate’s stock valued at $113,990,000 after acquiring an additional 77,680 shares in the last quarter. Greenwoods Asset Management Hong Kong Ltd. purchased a new stake in shares of UnitedHealth Group in the third quarter worth approximately $57,814,000. Sava Infond d.o.o. grew its position in UnitedHealth Group by 160.2% during the third quarter. Sava Infond d.o.o. now owns 14,570 shares of the healthcare conglomerate’s stock valued at $5,031,000 after purchasing an additional 8,970 shares in the last quarter. Finally, Aire Advisors LLC lifted its position in UnitedHealth Group by 40.4% in the 3rd quarter. Aire Advisors LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $598,000 after buying an additional 498 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Barclays decreased their target price on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a research report on Friday, January 30th. Oppenheimer decreased their price objective on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. UBS Group dropped their target price on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Finally, Jefferies Financial Group lowered their price target on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $290.11 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The firm’s 50-day moving average is $316.85 and its 200-day moving average is $324.23. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a market cap of $262.79 billion, a price-to-earnings ratio of 21.99, a PEG ratio of 1.33 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. During the same quarter in the prior year, the firm posted $6.81 EPS. The company’s revenue for the quarter was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.